{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:32:08Z","timestamp":1784381528894,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T00:00:00Z","timestamp":1560384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200141\/Z\/15\/Z"],"award-info":[{"award-number":["200141\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012618","name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ajo.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T02:23:12Z","timestamp":1561515792000},"page":"144-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Evaluating the Impact of Uveitis on Visual Field Progression Using Large-Scale Real-World Data"],"prefix":"10.1016","volume":"207","author":[{"given":"Xiaoxuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Montesano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7849-0087","authenticated-orcid":false,"given":"Alastair K.","family":"Denniston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Crabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ajo.2019.06.004_bib1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/bjo.80.9.844","article-title":"The possible impact of uveitis in blindness: a literature survey","volume":"80","author":"Suttorp-Schulten","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2019.06.004_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00005792-200107000-00005","article-title":"Chronic severe uveitis: etiology and visual outcome in 927 patients from a single center","volume":"80","author":"Bodaghi","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajo.2019.06.004_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/archopht.1962.00960030506014","article-title":"Epidemiology of uveitis. Incidence and prevalence in a small urban community","volume":"68","author":"Darrell","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2019.06.004_bib4","first-page":"1","article-title":"The reported demography and causes of blindness throughout the world","volume":"40","author":"Goldstein","year":"1980","journal-title":"Adv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2019.06.004_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/09273948.2014.968671","article-title":"The Manchester Uveitis Clinic: The first 3000 patients, 2: Uveitis Manifestations, Complications, Medical and Surgical Management","volume":"23","author":"Jones","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2019.06.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2012.04.006","article-title":"Glaucoma and uveitis","volume":"58","author":"Siddique","year":"2013","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2019.06.004_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00061198-200404000-00003","article-title":"Risk factors for elevated intraocular pressure in uveitis","volume":"13","author":"Herbert","year":"2004","journal-title":"J Glaucoma"},{"issue":"2","key":"10.1016\/j.ajo.2019.06.004_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajo.2009.02.032","article-title":"Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response","volume":"148","author":"Sallam","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2019.06.004_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0021-5155(02)00549-X","article-title":"A clinical evaluation of uveitis-associated secondary glaucoma","volume":"46","author":"Takahashi","year":"2002","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2019.06.004_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2007.135012","article-title":"Practical recommendations for measuring rates of visual field change in glaucoma","volume":"92","author":"Chauhan","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2019.06.004_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bjophthalmol-2016-309313","article-title":"The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema","volume":"101","author":"Egan","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.06.004_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajo.2017.05.020","article-title":"The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group: Report 3: baseline retinopathy and clinical features predict progression of diabetic retinopathy","volume":"180","author":"Lee","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2019.06.004_bib13","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/eye.2015.161","article-title":"Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data","volume":"29","author":"Boodhna","year":"2015","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2019.06.004_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamaophthalmol.2014.4237","article-title":"Measurement precision in a series of visual fields acquired by the Standard and Fast versions of the Swedish Interactive Thresholding Algorithm: analysis of large-scale data from clinics","volume":"133","author":"Saunders","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2019.06.004_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1167\/iovs.13-13006","article-title":"Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime","volume":"55","author":"Saunders","year":"2014","journal-title":"Invest Opthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2019.06.004_bib16","series-title":"National Electronic Glaucoma Surgery and Visual Field Preservation Audit: Feasibility Report","year":"2018"},{"issue":"4","key":"10.1016\/j.ajo.2019.06.004_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/13.4.10","article-title":"The visualFields package: a tool for analysis and visualization of visual fields","volume":"13","author":"Marin-Franch","year":"2013","journal-title":"J Vis"},{"issue":"1","key":"10.1016\/j.ajo.2019.06.004_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-016-1849-9","article-title":"More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England","volume":"16","author":"Boodhna","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"10.1016\/j.ajo.2019.06.004_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-#","article-title":"Confidence intervals for directly standardized rates: a method based on the gamma distribution","volume":"16","author":"Fay","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.ajo.2019.06.004_bib20","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J Stat Softw"},{"issue":"11","key":"10.1016\/j.ajo.2019.06.004_bib21","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1167\/iovs.12-10049","article-title":"Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR)","volume":"53","author":"O\u2019Leary","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2019.06.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22040","article-title":"Combining optical coherence tomography with visual field data to rapidly detect disease progression in glaucoma: a diagnostic accuracy study","volume":"22","author":"Garway-Heath","year":"2018","journal-title":"Health Technol Assess (Rockv)"},{"key":"10.1016\/j.ajo.2019.06.004_bib23","first-page":"T4","article-title":"Evaluation of visual field and imaging outcomes for glaucoma clinical trials (an American Ophthalomological Society Thesis)","volume":"115","author":"Garway-Heath","year":"2017","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"7","key":"10.1016\/j.ajo.2019.06.004_bib24","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1167\/iovs.14-14643","article-title":"Rates of glaucomatous visual field change in a large clinical population","volume":"55","author":"Chauhan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2019.06.004_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2017.06.003","article-title":"Risk factors for rapid glaucoma disease progression","volume":"180","author":"Chan","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2019.06.004_bib26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archophthalmol.2009.165","article-title":"Glaucoma with early visual field loss affecting both hemifields and the risk of disease progression","volume":"127","author":"De Moraes","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2019.06.004_bib27","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1755-3768.2012.02492.x","article-title":"Rates of visual field progression in clinical glaucoma care","volume":"91","author":"Heijl","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2019.06.004_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/aos.12788","article-title":"Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1","volume":"93","author":"Aptel","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2019.06.004_bib29","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1167\/iovs.11-8639","article-title":"Incorporating risk factors to improve the assessment of rates of glaucomatous progression","volume":"53","author":"Medeiros","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2019.06.004_bib30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/OPX.0b013e31818b9b40","article-title":"Is there evidence for continued learning over multiple years in perimetry?","volume":"85","author":"Gardiner","year":"2008","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2019.06.004_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archopht.1996.01100130017003","article-title":"The effect of perimetric experience in patients with glaucoma","volume":"114","author":"Heijl","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2019.06.004_bib32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1755-3768.1991.tb02713.x","article-title":"Long-term follow-up of baseline learning and fatigue effects in the automated perimetry of glaucoma and ocular hypertensive patients","volume":"69","author":"Wild","year":"1991","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2019.06.004_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00002512-199915060-00004","article-title":"Corticosteroids and glaucoma risk","volume":"15","author":"Tripathi","year":"1999","journal-title":"Drugs Aging"},{"issue":"6","key":"10.1016\/j.ajo.2019.06.004_bib34","first-page":"1274","article-title":"Intraocular pressure response to topical corticosteroids","volume":"24","author":"Armaly","year":"1965","journal-title":"Fed Proc"},{"issue":"8","key":"10.1016\/j.ajo.2019.06.004_bib35","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.ophtha.2013.01.025","article-title":"Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial","volume":"120","author":"Friedman","year":"2013","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2019.06.004_bib36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00417-009-1036-3","article-title":"Efficacy and safety of latanoprost in eyes with uveitic glaucoma","volume":"247","author":"Markomichelakis","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4-5","key":"10.1016\/j.ajo.2019.06.004_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/08820538.2011.588650","article-title":"The use of prostaglandin analogs in the uveitic patient","volume":"26","author":"Horsley","year":"2011","journal-title":"Semin Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2019.06.004_bib38","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ophtha.2007.10.031","article-title":"Intraocular pressure fluctuation","volume":"115","author":"Caprioli","year":"2008","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2019.06.004_bib39","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","article-title":"Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study","volume":"111","author":"Nouri-Mahdavi","year":"2004","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2019.06.004_bib40","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ajo.2007.07.040","article-title":"Association between intraocular pressure variation and glaucoma progression: data from a United States chart review","volume":"144","author":"Lee","year":"2007","journal-title":"Am J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939419302715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939419302715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:41:16Z","timestamp":1762080076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939419302715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"alternative-id":["S0002939419302715"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2019.06.004","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the Impact of Uveitis on Visual Field Progression Using Large-Scale Real-World Data","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}